chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have very swollen feet. It started around 2-15-2021 the swelling in my feet. I went to see my primary doctor, and they put me on Keflex 500 mg  for 10 days, it's now been 8 days & I still have swelling.  I went to Emergency department on Saturday night because both of my feet were so swollen, and I was shivering, and was scared since I live alone. I was there for many hours, & the dr. prescribed Naproxen for 7 days twice a day. It's a very strong medication, which I don't normally take. They gave me 1 tablet when I was there, & it seemed to help a bit, so was hopeful it would help.  I've now been taking the Naproxen for 4 days, along w/antibiotics for 8 days, & my feet are very swollen today, I'm very concerned. I also have a nodule in the inside of my right hand that I didn't have before. When I went to the doctor last Wednesday, 2-17-2021, I had so much pain on the ball of my feet, & could hardly walk very far, it hurt so bad just to walk on the ball of my feet, even in my home.  Normally I'm very active, could walk my dog up & down my stairs & around the large complex several times, when this happened it hurt so bad to walk, I would have to stand on my tippy toes, take my dog out, & come right back in, since I work remotely.
Patient received 2nd dose Pfizer @ 1549, after 10 minutes of monitoring patient c/o of tightness & felt "slow swelling" in her throat. Also reporting "slow swallowing sensation" Patient brought out to back triage area, vitals stable, NO SOB, no wheezing, no lip or tongue swelling noted. 167/95, 63, 99% RA. Reporting feeling anxious. Only allergy or similar event patient reports is medication, ephedrine during delivery which was treated w/ O2 during her delivery  Repeat vitals 134/90, 59, 99%  Allergy MD on call notified of event, per MD continue to monitor for additional 30 minutes and call back w/ any further symptoms 136/93, 60 & 99%  After 30 minutes, patients vitals stable, sensation has resolved & felt well enough to go home 127/92, 59 & 99%
trouble walking, 102-103 fever, extreme fatigue for 2 days, nausea, headache that didn't go away with meds.  Temp stayed high for all 4 days, nausea went away after 2-3 days, headache went away  after about  2 1/2 days.
From start of left shoulder to elbow, arm became swollen and red after 1 day of receiving both vaccines. Patient taken Aleve and used ice to decrease swelling and pain. Left arm became stiff and unable to move properly. Patient described to the left arm to be in a paralyzed with the arm flexed. Patient received new prescriptions for a arm brace and prednisone after 4 days of receiving the vaccines.
GENERAL FATIGUE; MUSCLES ACHES; This spontaneous report received from a patient concerned a 55 year old male. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 10:30 on left arm for prophylactic vaccination. No concomitant medications were reported.  On 26-MAR-2021, the subject experienced general fatigue. On 26-MAR-2021, the subject experienced muscles aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from general fatigue, and muscles aches. This report was non-serious.
Severe soreness & tightening of the throat for a period of about 36 hours.
Pt experienced fainting response to injection shortly after receiving vaccine. Pt stated feeling of faintness, temporarily loss of vision and hearing, and dizziness. Pharmacist observed that pt was shaking and pale. Pt did not fully lose consciousness and was instructed to lie down flat on a cot  and be observed for 30 minutes (until 10:45AM). Pt's blood pressure was monitored (normal range 115/76). Pt was given water and reported significant improvement within 3 minutes. Pt reported history of anxiety and fainting to blood draws/vaccines in the past.
Tongue swelling, trouble swallowing, nausea, headache, pain in arm within 15-30  minutes. Severe fatigue, nausea, pain  in arm headache, fever, loss of appetite, weakness, trouble with eyesight and concentration within 24 hours. 24 hours after vaccine until today, 1/04/2022, 7 days later, headaches, weakness, pain in arm largely around vaccine injection area, problems with eyesight, tingling and numbness in fingers and toes on right side, difficulty concentrating .
numbness around injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPOAESTHESIA (numbness around injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included AMLODIPINE and ATORVASTATIN CALCIUM for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE HYPOAESTHESIA (numbness around injection site). At the time of the report, VACCINATION SITE HYPOAESTHESIA (numbness around injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Event outcome updated.
Due date was August 23, 2017. Premature birth a week after the shot. Placenta tested to have Chorioamniocentesis, which may be a possible reason for premature delivery. Patient had mild preeclampsia, and endometritis accompanied by 102 degrees fever after 72 hours of delivery.
pt recvd vax; 2 wks later exp rt shoulder pain radiating to rt fingers which became swollen & numb; exp dec func in arms; resolved
(R) arm deltoid swelling, erythema, low grade fever. ER visit on 11/17/07 - Keflex IV, Prednisone and Keflex P.O.
3 days after vaccination, the arm (Rt) swelled, turned red around the arm and down to the elbow. He had a fever (103 degrees F) for 3 days, feeling sick. He still is red and skin is peeling on arm now. The red/peeling skin has been over the last 3 weeks. The fever, malaise subsided after 3 days.
pt recv vax 22MAY96 & pt broke out in a rash the next day;mom called 30MAY96 to report rash was worse on 29MAY96;mom had given DPH & sent to school;parent stated rash was better p/school 30MAY96 ;could not see MD until next day
Patient was unknowingly given Dose #1 with expired vaccine.  Patient was contacted by his provider once the error was realized
15 mins after vaccine given, pt had mild itchy throat with mild HA. consulted with MD. Zyrtec given. symptoms resolved in 25 mins. pt went home
PATIENT FELT LIGHTHEADED WHEN RETURNING TO WORK AFTER RECEIVING DOSE 1 OF THE  MODERNA COVID-19 VACCINE. PATIENT HAD TO STEP OUT OF A SURGICAL CASE TO SIT DOWN. PATIENT HAD PALE APPEARANCE.. PATIENT STATED THAT SHE HAD NOT ATE ALL DAY DUE TO A BUSY WORK DAY. SYMPTOMS RESOLVED WITHIN A COUPLE HOURS. NO RECURRING SYMPTOMS NOTED
Patient stated that when she received the vaccine she felt pain in her arm like a "waterfall effect".  Patient experienced continued pain after the inject with a pain scale of 9.  Patient stated on (10/11/23) that the pain has lessened but she has pain when she raises her left arm into the air at the shoulder.  Patient reports pain is now about a 5.  Patient stated that she did not have any swelling or redness at the injection site or arm.
did not feel well for several days.; Vomiting; fatigue; diarrhea; stomach cramping in the lower right side; loss of appetite; nausea; trouble passing gas and not being able to burp which caused bloating; not being able to burp; bloating; soreness at the injection site; soreness at the injection site / with a lump; shivering; headache; This case was reported by a nurse and described the occurrence of injection site pain in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 31st December 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 31st December 2020, less than a day after receiving Shingrix, the patient experienced injection site pain and injection site lump. On 1st January 2021, the patient experienced fatigue, diarrhea, stomach cramps, appetite lost, nausea, gas, burping, bloating, shivering and headache. On 2nd January 2021, the patient experienced vomiting. On an unknown date, the patient experienced feeling unwell. On 6th January 2021, the outcome of the injection site pain and injection site lump were recovered/resolved. In January 2021, the outcome of the fatigue, diarrhea, stomach cramps, appetite lost, nausea, gas, burping, bloating, shivering, headache, feeling unwell and vomiting were recovered/resolved.   It was unknown if the reporter considered the injection site pain, injection site lump, fatigue, diarrhea, stomach cramps, appetite lost, nausea, gas, burping, bloating, shivering, headache, feeling unwell and vomiting to be related to Shingrix.  Additional details were provided as follows: The patient was also a nurse. The patient received Shingrix in left arm. The patient experienced soreness at the injection site the day of the vaccine administration with a lump that lasted 6 days. The day following the vaccine administration, she experienced fatigue, diarrhea, stomach cramping in the lower right side of the stomach, loss of appetite, nausea and trouble passing gas and not being able to burp which caused bloating. These symptoms lasted several days. She also reported shivering and a headache the day following the vaccine administration and both lasted 24 hours. Vomiting presented 2 days later, on 2nd January 2021 that lasted 3 to 4 hours before resolving. The patient said she just did not feel well for several days. The reporter did not consent to follow up.
achiness and fatigue followed by chest pain/pressure and extreme shortness of breath. Pt also experiencing urinary retention and pain when urinating
Started having chills and not feeling well about 9pm. Chills got stronger through the night and caused me not to sleep.  My blood pressure was elevated per my fitbit tracker readings and I was a little worried at times as well. Chills continued all night long and did not stop no matter how many blankets I put on while in bed. However, holding my hair dryer to my body and extremities did help the shivering, but then shortly returned for a while before I was able to fall asleep around 3-4am. The next day I did not feel myself, ended up having an anxiety attack and had to call 911 which they confirmed I probably hyper-vinylated. Still had chills for like 2 straight days on an off and no apatite at all during this time, not even warm soup and crackers.
This spontaneous report as received from a Nurse refers to an unspecified patient of an unknown age and gender. The patient's relevant medical history, concurrent condition and concomitant medication were not reported. On 31-AUG-2010, the patient was vaccinated with RECOMBIVAX HB injection dose 1, (lot number and dosage not reported) "soon after their birth". Then was administered with the second and third doses of RECOMBIVAX HB on 12-MAY-2015 and 29-JUN-2015, respectively. This was outside the labeled recommendations in the RECOMBIVAX HB prescribing information. No adverse effect reported. There were no product quality complaints (PQC) involved. No further information was provided. Additional information has been requested.
Sudden increase in blood pressure to over 172/122 one week after taking 1st dose of Moderna and has persisted  for over three weeks now. Dizziness, shortness of breath momentarily and inconsistent heart/chest pain.  Treatment: Attempting different blood pressure medication, stress test, and in process on some lab tests and Echocardiogram ordered by my PCP.  Outcome: Medication ineffective.
Hospitalized;  COVID-19 positive (9.2.21);  fully vaccinated Admission Date: 9/3/2021 Discharge Date: 09/04/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Stroke-like symptom [R29.90] Cerebrovascular accident (CVA), unspecified mechanism  COVID-19    HOSPITAL COURSE:  SUBJECTIVE: Patient is a 43 y.o. female who presents today with her husband at bedside. After she developed symptoms of acute aphasia, left sided weakness, left sided numbness and a headache at a ball game 9/2/2021 @ 1430, she remembers it being the bottom of the third, she felt whole body tingling sensation, had a brief "black out" for seconds and felt hot, ushers took her to the medical bay at the park, she then was sent to hospital due to concern for stroke. She was given tPA at 1600 9/2/2021. She recalls the providers talking to her about tPA and the risks and they had to call her husband because she was unable to answer their questions.    Then she was in the  ED, and they told her they were going to get an MRI and stroke evaluation, though there were no beds available in the ICU  and she would need to be watched in the ED. Patient states she did not feel like she was being observed in the ED, so she left AMA with her husband to drive 3 hours from hospital to another facility for management and workup for possible stroke.  43 y.o. female presenting from Hospital after patient left AMA status post tPA.  Reportedly patient was at baseball game.  She was in the lower section, sitting in the sun and went to walk up the steps.  She said there were a lot of them.  During the ascension she started feeling warm and needed to sit down.  She felt tingling on both sides of her body.  She said paramedics took her BP and all she recalls was being told it was low in the 80's and that they couldn't measure the other number.  She also recalls having difficulty getting words out.  She was taken to the hospital where it was suggested that she may have a facial droop.  She was given a mirror and recalls telling them that it looked like her face.  She was given tPA at 4:00 p.m with resolution of symptoms approximately 5:30 p.m on 09/02/2021.  Onset of symptoms was roughly 2-3 pm.  Patient was unhappy with the care received via an emergency room and decided to seek care elsewhere.  Now at this hospital, patient reports she is back to normal.  MRI brain was negative for acute abnormality.  It was not obtained with contrast but there is no evidence of chronic lesions with demyelinating appearance.  Etiology considered likely pre-syncopal d/t hypotensive event.  Echo without clear abnormality but suggesting atypical septal motion in one sequence.  I discussed with cardio who suggested this would not be expected to elicit a syncopal event and did not require follow-up.  Patient with sinus arrythmia while tele and will obtain ziopatch at discharge.  Patient should modify stroke risk factors for primary prevention, including glycemic control through diet and exercise as A1c 6.0.  Recommend marijuana cessation.  Otherwise patient should f/u with PCP post-hospitalization and for resolution of UTI treated with Azithromycin.  Otherwise EEG pending read at discharge.  Patient discharged home.
Pt died suddenly from cardiac arrhythmia while walking dog. Paramedics attempted resuscitation. Pt did not respond to resuscitation efforts in the field or in the ER. Pronounced dead at 17:45. Autopsy report rec'd 10/31/2005 -- complete as reported.
Had local redness about 2 inches and itching and tightness in her throat relieved by Benadryl.
Administered outside of approved age range. Administered to a 10 year old patient; This non-serious case was reported by a other health professional via patient support programs and described the occurrence of inappropriate age at vaccine administration in a 10-year-old male patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   On 01-NOV-2021, the patient received Pediarix. On 01-NOV-2021, an unknown time after receiving Pediarix, the patient experienced inappropriate age at vaccine administration (Verbatim: Administered outside of approved age range. Administered to a 10 year old patient). The outcome of the inappropriate age at vaccine administration was unknown.   Additional Information: GSK Receipt Date: 09-MAY-2023 Pediarix manufacturer was not specified. No information was provided regarding subsequent dose (administered outside of approved age range), additional information about the adverse event, maladministration outside of approved age range. The reporter did not consent to follow-up. The patient received Pediarix at an inappropriate age, which led to inappropriate age at vaccine administration.
Patient came into the pharmacy on 12/15/18 for another reason and stated that her arm has been sore and reduced mobility since her SHINGRIX vaccination in May. Recommended seeking medical attention.
One week after the vaccine, I developed hives in the arm where the shot occured. Then, it has now spread and I have hives on my arms and legs.
Vomiting; felt feverish; excess phlegm in the throat. IV fluid bolus, ondansetron, lab.
Redness/blister (fluid filled) 24 hours later on thighs at shot site LLT - progressed over next 24 hours - abscessed. 1 shot administered 2 blisters/2 areas.
Approximately 8-12 hrs after vaccine administration parents observed nickel-size swelling at injection site. Over the next 48 hrs, parents report that swelling gradually increased to the size of a softball and included localized redness and pain. Fever (Tmax 101) began 48 hrs after administration. Parents report redness, swelling, and pain were treated with ibuprofen, Benadryl, and ice at home. Due to ongoing redness, swelling, pain, and fever, parents were seen in our office approx 72 hrs after administration and diagnosed with localized vaccine reaction. Treatment recommendation included tylenol/ibuprofen, rest, and ice. Parents advised to follow-up with our office if symptoms worsened or did not improve. Awaiting confirmation of complete resolution of symptoms from family.
This spontaneous report as received from a licensed vocational nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # L018351, expiration date 11-AUG-2017 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of minimum 34 degrees Fahrenheit for 12 hours and a maximum 50 degrees Fahrenheit for 12 hours. This is one of several reports received from the same reporter. Additional information has been requested.
Information had been received from a female who reported that her sister was injected with PNEUMOVAX23 by her physician on 10-JAN-2013 during a physical exam. It was immediately after her well physical that the patient had begun her "own respiratory nightmare". The patient began wheezing and having trouble breathing the very weekend following her pneumonia vaccination. She had several emergency room visits and was then hospitalized for over a week. Following discharge, the patient was sent to rehabilitation for another week. When the patient finally got back to her independent apartment, she continued to have the same breathing and wheezing issues. Thinking it was possibly being exacerbated by secondhand smoke, the patient's sister moved her to a nursing rehabilitation center. At the time the patient first became ill, she never even thought of the vaccination. Patient was taken off of the vitamin D that her physician had ordered thinking she may be allergic to it. The patient's sister noted that they never thought it could have been related to the pneumonia vaccine. At this time, the patient battles her breathing issues every day. The reporter who also had events with PNEUMOVAX23 (see MARRS# 1309USA014552 stated she woke up with a real feeling of constriction in the lower part of her lungs. She realized that she was no longer normally breathing from the diaphragm, but only from her upper chest. It was a very shallow and difficult breathing pattern. When she tried to take deep breaths to the diaphragm, she could make the air go there, but it hurt. This was the exact breathing pattern that her sister had begun to use. Deep breathing was hard for her sister. Her sister simply had not recovered with all the best medical attention she had been able to access. It was reported that the patient had lost her freedom and all her wordly possessions at 61 years of age. This time last year that patient was doing well and had no breathing issues. Now she was on multiple nebulizer treatments a day and nothing stops the wheeze. The patient was now confined to a wheelchair. On 30-AUG-2013, patient saw her physician who had been working with her since the hospitalization. Physician scheduled a scope of the patient's bronchial tubes in an effort to find out what was wrong. The patient began to use a breathing pattern that included taking deep breaths to the diaphragm because deep breathing was hard for her. The patient's sister reported that she knew PNEUMOVAX23 caused her illness and knew that her sister had the exact same thing happen to her. The patient's sister also noted she was doubtful the patient would ever be okay again as she was already handicapped from a car wreck at the age of 18. Wheezing, trouble breathing, and shallow breathing were considered to be disabling. This is one of several reports from the same source. Additional information has been requested.
Many small red hives on the upper lip inside the mouth. Pain when making movements in the area of the condition.
This spontaneous reports as received from a nurse refers to an unspecified number of adult patients (no patient information was provided). On an unknown date the patients were vaccinated with the first dose of MMR II (dose, route and lot # not reported). The patients did not develop immunity after their first dose of MMR II. No adverse effects were reported. The outcome for patients and relatedness between MMR II and adverse event were not provided. This is one of several reports received from the same reporter. Additional information has been requested.
9:15 pm - pt complains of "something stuck in throat" and "feeling tired". Self admin. BENADRYL with no relief. In bed 30 minutes - lips tingling, throat "tighter", eyes, lips & face swollen, chest - "bright red". Drive to ER by daughter. Decreased in swallowing difficulty at ER. MD admin. ZANTAC, steroids & BENADRYL with relief. Discharged 4:30 am on 10/26/11 with 5 day Rx of ZANTAC, steroid, BENADRYL.
As I injected the needle into the patient the  needle and syringe separated.   The patient did not receive the vaccine that time.  I redrew medication in new syringe and needle tip and gave patient the vaccine.  Patient saw that they didn't receive it initially so was ok
1st shingles shot on 11/13/20 / didn't get the 2nd one; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st dose on 13th November 2020).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting the patient did not receive 2nd shot of Shingles vaccine, which led to incomplete course of vaccination. The patient asked that he/she need to start over. The follow-up could not be possible as no contact details were available.
fever on and off one week, body aches two weeks, fatigue two weeks, arm sore/burning over two weeks
Large urticarial reaction with area (central) of erythema & heat at SC site of MMRV. Patient given ROCEPHIN 1gm IM & BENADRYL 50 mg IM.